Treatment with specific and pan-plasma membrane calcium ATPase (PMCA) inhibitors reduces malaria parasite growth in vitro and in vivo

BACKGROUND: Rapid emergence of Plasmodium resistance to anti-malarial drug mainstays has driven a continual effort to discover novel drugs that target different biochemical pathway (s) during infection. Plasma membrane Calcium + 2 ATPase (PMCA4), a novel plasma membrane protein that regulates Calciu...

Descripción completa

Detalles Bibliográficos
Autores principales: Asih, Puji B. S., Siregar, Josephine E., Dewayanti, Farahana K., Pravitasari, Normalita E., Rozi, Ismail E., Rizki, Andita F. M., Risandi, Rifqi, Couper, Kevin N., Oceandy, Delvac, Syafruddin, Din
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241181/
https://www.ncbi.nlm.nih.gov/pubmed/35768835
http://dx.doi.org/10.1186/s12936-022-04228-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241181/
https://www.ncbi.nlm.nih.gov/pubmed/35768835
http://dx.doi.org/10.1186/s12936-022-04228-0

Ejemplares similares